Antimicrobial resistance inNeisseria gonorrhoeaecompromises gonorrhoea treatment worldwide. Novel and optimized treatments and/or treatment strategies that effectively eradicate the infection with low selection of resistance are imperative. A new prospective clinical study provides further evidence that resistance-guided treatment of gonorrhoea with single-dose oral ciprofloxacin is efficacious in relevant settings and can reduce the selection pressure for resistance.
Funding Agencies:
World Health Organization
Global Antibiotic Research and Development Partnership (GARDP)
Research Committee of Örebro County
Örebro University Hospital Foundation, Örebro, Sweden